Evidence-based information guides to rare chromosome disorders for families and professionals
© Searle et al; licensee BioMed Central Ltd. 2010
Published: 19 October 2010
The purpose of this project is to develop reliable, relevant, accurate leaflets for affected families and health (and other) professionals that fill an information gap about rare chromosome disorders. In 2003 Unique surveyed information materials published in the UK about specific rare chromosome disorders: for over 93% of members, no accessible disorder-specific information was available. Unique asked families what they most wanted to know at diagnosis and what questions remained unanswered. Unique prioritised 66 disorders according to frequency on its database (7,140 member families at February 2010) and absence of existing information accessible to families. Information was compiled from the medical literature, from Unique’s database and from detailed surveys sent to member families. Draft texts were reviewed for accuracy by Unique’s medical adviser and by medical and genetics professional experts in the specific disorders. Photographically illustrated draft leaflets were vetted for content by families. By early 2010, leaflets have been developed on 113 rare chromosome disorders including numerical and structural disorders, subtelomere deletions, mosaic disorders, emerging microdeletion and microduplication syndromes and a broad range of less common diagnoses. Twenty-one leaflets have been translated into at least one European language. Many more leaflets are in preparation or planned. Leaflets are available free to families and the professionals who work with them either in print format or online from Unique’s website at http://www.rarechromo.org. The leaflets improve families’ understanding and acceptance of a rare chromosome disorder and help diminish the acute stress and anxiety associated with diagnosis. They are also proving to be a useful resource for professionals, including health professionals in clinic.
This article is published under license to BioMed Central Ltd.